Shares of Centene Corp (NYSE: CNC) shot up over 3% on average volume on Friday, after it was revealed that activist investor and CEO of asset management firm Third Point, Daniel Seth Loeb, has sought for the company’s sale.
According to The Wall Street Journal, Third Point holds at least a $300 million worth of stake in the insurance firm.
Loeb reportedly wants Centene to sell itself before it consummates the deal to buy WellCare Health Plans (NYSE: WCG) for $15.3 billion. The deal was announced in March this year, and both the companies are set to have shareholder meetings next month to sort out differences and go forward with the deal.
READ: WHAT YOU NEED TO KNOW BEFORE BUYING VILLAGE FARMS STOCK
Other activist investors including Corvex Management and Sachem Head Capital Management had also earlier put forward similar demands.
However, earlier this month, Centene chief Michael Neidorff said in a letter that the deal was under regulatory process and they are planning to go ahead with it.
Shares of health insurers Humana (NYSE: HUM) and UnitedHealth Group (NYSE: UNH) also spiked during intra-day trading on the likelihood of being a potential match to Centene. Shares of WellCare Health, meanwhile, fell into the red zone.
Most Popular
CVX Earnings: Chevron reports lower revenue and profit for Q1 2024
Energy exploration company Chevron Corporation (NYSE: CVX) announced first-quarter 2024 financial results, reporting a decline in net profit and revenues. Net income attributable to Chevron Corporation was $5.50 billion or
ABBV Earnings: AbbVie reports lower adj. profit for Q1 2024; revenue edges up
Specialty biopharmaceutical company AbbVie, Inc. (NYSE: ABBV) Friday announced first-quarter 2024 financial results, reporting a decline in adjusted earnings and a modest rise in revenues. The company reported worldwide net
CL Earnings: Key quarterly highlights from Colgate-Palmolive’s Q1 2024 financial results
Colgate-Palmolive Company (NYSE: CL) reported first quarter 2024 earnings results today. Net sales increased 6.2% year-over-year to $5.06 billion. Organic sales increased 9.8%. Net income attributable to Colgate-Palmolive Company was